Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Alcohol and disadvantaged men: developing a brief intervention for delivery by mobile phone
ISRCTN ISRCTN10515845
ClinicalTrials.gov identifier
Public title Alcohol and disadvantaged men: developing a brief intervention for delivery by mobile phone
Scientific title Reducing alcohol-related harm in disadvantaged men: development and feasibility assessment of a brief intervention delivered by mobile phone
Acronym N/A
Serial number at source 1.1
Study hypothesis Can a brief intervention delivered by mobile reduce heavy drinking among disadvantaged young to middle aged men?
Lay summary
Ethics approval Tayside Committee on Medical Research Ethics A approved on the 13th November 2009 (ref: 09/S1401/78)
Study design Feasibility study with a randomised controlled component
Countries of recruitment United Kingdom
Disease/condition/study domain Alcohol related problems
Participants - inclusion criteria 1. Men aged 25 - 44 years
2. Living in deprived urban communities
3. Have consumed 8 or more units of alcohol in a single drinking session at least twice in the preceding four weeks
Participants - exclusion criteria Cannot communicate (verbally and by text message) in English
Anticipated start date 01/03/2010
Anticipated end date 30/11/2011
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Phase 1: 50 focus group participants; Phase 2: 60 men; Phase 3: 20 men recruited from Phase 2
Interventions A series of 28 interactive text messages and images to be delivered over a four week period to participants in both arms of the study. The intervention group will receive messages to address four areas:
1. Increasing awareness of and perceived risk of experiencing alcohol-related harm
2. Modifying the balance between perceived benefits and harms of alcohol
3. Addressing misperceptions about alcohol consumption by peers
4. Increasing the ability to refuse drinks

The comparator group will receive the same number of text messages and images. These will cover the general health promotion messages from current government public health policy. These include diet, physical activity, smoking and mental wellbeing.

The total duration of the intervention is 28 days. Participants will be followed up for three months.
Primary outcome measure(s) The change in frequency of heavy drinking (consumption of 8 or more units in a single session), measured at three months.
Secondary outcome measure(s) Measured at three months:
1. The extent to which the intervention has influenced perceptions of harms
2. The benefits of moderated drinking
3. Intentions for future drinking
Sources of funding National Institute for Health Research (NIHR) (UK) - Public Health Research Programme (ref: 09/3001/09)
Trial website
Publications
Contact name Prof  Iain K  Crombie
  Address Department of Public Health
Division of Clinical & Population Sciences & Education
Mackenzie Building
Kirsty Semple Way
  City/town Dundee
  Zip/Postcode DD2 4BF
  Country United Kingdom
  Tel +44 (0)1382 420 102
  Fax +44 (0)1382 420 101
  Email i.k.crombie@cpse.dundee.ac.uk
Sponsor University of Dundee (UK)
  Address Research and Innovation Services
11 Perth Road
  City/town Dundee
  Zip/Postcode DD1 4HN
  Country United Kingdom
  Tel +44 (0)1382 344 644
  Fax +44 (0)1382 202 178
  Email j.houston@dundee.ac.uk
  Sponsor website: http://www.dundee.ac.uk/
Date applied 17/12/2009
Last edited 17/02/2010
Date ISRCTN assigned 17/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central